These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9263696)

  • 1. Premenstrual syndrome: current perspectives on treatment and etiology.
    Freeman EW
    Curr Opin Obstet Gynecol; 1997 Jun; 9(3):147-53. PubMed ID: 9263696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical management of premenstrual dysphoric disorder.
    Yonkers KA
    J Gend Specif Med; 1999; 2(3):55-60. PubMed ID: 11252853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-antidepressant treatment of premenstrual syndrome.
    Pearlstein T; Steiner M
    J Clin Psychiatry; 2000; 61 Suppl 12():22-7. PubMed ID: 11041381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder.
    Segebladh B; Borgström A; Nyberg S; Bixo M; Sundström-Poromaa I
    Am J Obstet Gynecol; 2009 Aug; 201(2):139.e1-8. PubMed ID: 19398092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen.
    Sundström I; Nyberg S; Bixo M; Hammarbäck S; Bäckström T
    Acta Obstet Gynecol Scand; 1999 Nov; 78(10):891-9. PubMed ID: 10577620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: a meta analysis.
    Wyatt KM; Dimmock PW; Ismail KM; Jones PW; O'Brien PM
    BJOG; 2004 Jun; 111(6):585-93. PubMed ID: 15198787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal management of premenstrual syndrome.
    Usman SB; Indusekhar R; O'Brien S
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):251-60. PubMed ID: 17761457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discussion: 'Add-back regimens in patients using a GnRH agonist for premenstrual dysphoric disorder' by Segebladh et al.
    Jungheim ES; Kenerson JJ; Foyouzi-Yousefi N; Allsworth JE; Marquard KL
    Am J Obstet Gynecol; 2009 Aug; 201(2):e1-5. PubMed ID: 19646561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating premenstrual dysphoric disorder. Options include drugs targeting serotonin and various types of hormone therapy.
    Harv Ment Health Lett; 2009 Oct; 26(4):4-5. PubMed ID: 19904834
    [No Abstract]   [Full Text] [Related]  

  • 10. Premenstrual syndrome.
    DeMonico SO; Brown CS; Ling FW
    Curr Opin Obstet Gynecol; 1994 Dec; 6(6):499-502. PubMed ID: 7893953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New indications for antidepressive agents. Now also in anxiety disorders and premenstrual syndrome?].
    Hochstrasser B
    MMW Fortschr Med; 2000 Dec; 142(49-50):41-4. PubMed ID: 11190938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents.
    Rapkin AJ; Mikacich JA
    Curr Opin Obstet Gynecol; 2008 Oct; 20(5):455-63. PubMed ID: 18797268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The premenstrual syndrome. Effects of "medical ovariectomy".
    Muse KN; Cetel NS; Futterman LA; Yen SC
    N Engl J Med; 1984 Nov; 311(21):1345-9. PubMed ID: 6387488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Premenstrual syndrome].
    Quéreux C; Bory JP
    Contracept Fertil Sex; 1997 Nov; 25(11):826-32. PubMed ID: 9471286
    [No Abstract]   [Full Text] [Related]  

  • 15. Recognizing and treating premenstrual dysphoric disorder in the obstetric, gynecologic, and primary care practices.
    Ling FW
    J Clin Psychiatry; 2000; 61 Suppl 12():9-16. PubMed ID: 11041379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of premenstrual dysphoric disorder: an update.
    Steiner M; Born L
    Int Clin Psychopharmacol; 2000 Nov; 15 Suppl 3():S5-17. PubMed ID: 11195269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome.
    Nyberg S; Bäckström T; Zingmark E; Purdy RH; Poromaa IS
    Gynecol Endocrinol; 2007 May; 23(5):257-66. PubMed ID: 17558683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of estrous cycle-dependent marble burying in female rats by acute treatment with progesterone and antidepressants.
    Schneider T; Popik P
    Psychoneuroendocrinology; 2007 Jul; 32(6):651-9. PubMed ID: 17561352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The premenstrual syndrome.
    Watson NR; Studd JW
    Br J Hosp Med; 1990 Oct; 44(4):286-92. PubMed ID: 2249107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.
    Freeman EW
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():27-34; discussion 42-3. PubMed ID: 12659404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.